Showing results (1-10 of 491) with videos related to
Sort By:
Pageof 50
Cytokine & Growth Factor Reviews|July 8, 2010
Interleukin-25: a two-edged sword in the control of immune-inflammatory responsesGiovanni Monteleone, Francesco Pallone, Thomas T MacdonaldTrends in Pharmacological Sciences|July 21, 2009
Interleukin-21 as a new therapeutic target for immune-mediated diseasesGiovanni Monteleone, Francesco Pallone, Thomas T MacdonaldTrends in Immunology|September 15, 2004
Smad7 in TGF-beta-mediated negative regulation of gut inflammationGiovanni Monteleone, Francesco Pallone, Thomas T MacDonaldTrends in Immunology|April 29, 2008
Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responsesGiovanni Monteleone, Francesco Pallone, Thomas T MacDonaldCurrent Opinion in Pharmacology|October 18, 2011
Emerging immunological targets in inflammatory bowel diseaseGiovanni Monteleone, Francesco Pallone, Thomas T MacDonaldCytokine & Growth Factor Reviews|March 6, 2009
Interleukin-21 (IL-21)-mediated pathways in T cell-mediated diseaseGiovanni Monteleone, Francesco Pallone, Thomas T MacdonaldCurrent Opinion in Gastroenterology|March 28, 2012
The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesisIvan Monteleone, Thomas T MacDonald, Francesco Pallone, et al.Inflammatory Bowel Diseases|March 12, 2010
IL-23/IL-17 axis in IBDMassimiliano Sarra, Francesco Pallone, Thomas T Macdonald, et al.Current Drug Targets|December 18, 2009
Targeting interleukin-21 in immune-mediated pathologiesMassimiliano Sarra, Francesco Pallone, Thomas T Macdonald, et al.Oncoimmunology|June 28, 2012
Interleukin-21 in cancer immunotherapy: Friend or foe?Carmine Stolfi, Francesco Pallone, Thomas T Macdonald, et al.Pageof 50